Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Large B-Cell Lymphoma.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00869999
What this trial is testing

Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Massachusetts General Hospital 26
Testing effectiveness (Phase 2)Study completedNCT00695409
What this trial is testing

Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 122
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT06664411
What this trial is testing

Pola-ZR2P in Previously Untreated DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Navy General Hospital, Beijing 80
Not applicableNot Yet RecruitingNCT06656234
What this trial is testing

The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Ruijin Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00799136
What this trial is testing

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Who this might be right for
Lymphoma, AIDS RelatedHIV Infections
Ontario Clinical Oncology Group (OCOG) 6
Large-scale testing (Phase 3)Study completedNCT00118209
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Large B Cell Lymphoma
Alliance for Clinical Trials in Oncology 524
Not applicableUnknownNCT05784987
What this trial is testing

R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Early research (Phase 1)Study completedNCT02471911
What this trial is testing

KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Weill Medical College of Cornell University 22
Not applicableStudy completedNCT00889798
What this trial is testing

Tumor Registry of Lymphatic Neoplasia

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia (CLL)Multiple Myeloma (MM)
iOMEDICO AG 3,795
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Looking for participantsNCT07494565
What this trial is testing

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)CD5 Positive
Sun Yat-sen University 60
Not applicableStudy completedNCT07181785
What this trial is testing

Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas.

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Andrés José Maria Ferreri 555
Testing effectiveness (Phase 2)Study completedNCT00498043
What this trial is testing

Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma

Who this might be right for
Lymphoma, B-CellLymphoma, Large-Cell, Diffuse
Hospices Civils de Lyon 222
Early research (Phase 1)Study completedNCT03450343
What this trial is testing

Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Large B-Cell Diffuse Lymphoma
Medical University of South Carolina 9
Testing effectiveness (Phase 2)Study completedNCT03023878
What this trial is testing

Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma

Who this might be right for
High-risk Diffuse Large B-Cell Lymphoma
Amgen 47
Testing effectiveness (Phase 2)UnknownNCT03373019
What this trial is testing

Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
ChidamideLymphoma, B-CellLymphoma, Large B-Cell, Diffuse+13 more
Fudan University 63
Not applicableUnknownNCT05078840
What this trial is testing

PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors

Who this might be right for
Lymphoma, Non-Hodgkin's, Adult
Grupo Argentino de Tratamiento de la Leucemia Aguda 75
Testing effectiveness (Phase 2)Study completedNCT02998476
What this trial is testing

Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Who this might be right for
Lymphoma
Incyte Corporation 60
Next Page